Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd -

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd -

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

brenntag australia pty ltd - poly hexadecyl dimethyl siloxane - soluble concentrate - poly hexadecyl dimethyl siloxane emulsifiers & surfactants active 900.0 g/l - wetting agent - grape | grape - gordo and waltham | grape - muscat gordo blanco | grape - sultana | grapevine | vineyard - promote fruit drying | surfactant

Israel - English - Ministry of Health

padagis israel agencies ltd, israel - glyceryl trinitrate - ointment - glyceryl trinitrate 0.4 % - glyceryl trinitrate - glyceryl trinitrate - for relief of pain associated with chronic anal fissure. in the clinical development of the drug a modest effect has shown on improvement in average daily pain intensity.

New Zealand - English - Medsafe (Medicines Safety Authority)

apotex nz ltd - amoxicillin trihydrate 286.98mg equivalent to amoxycillin 250 mg - capsule - 250 mg - active: amoxicillin trihydrate 286.98mg equivalent to amoxycillin 250 mg excipient: allura red ac   brilliant blue fcf   colloidal silicon dioxide croscarmellose sodium gelatin phloxine b quinoline yellow stearic acid sunset yellow fcf titanium dioxide  

New Zealand - English - Medsafe (Medicines Safety Authority)

apotex nz ltd - amoxicillin trihydrate 573.96mg equivalent to amoxycillin 500 mg - capsule - 500 mg - active: amoxicillin trihydrate 573.96mg equivalent to amoxycillin 500 mg excipient: allura red ac   brilliant blue fcf   colloidal silicon dioxide croscarmellose sodium gelatin phloxine b quinoline yellow stearic acid sunset yellow fcf titanium dioxide  

New Zealand - English - Medsafe (Medicines Safety Authority)

apotex nz ltd - cilazapril monohydrate 5.22mg equivalent to 5 mg cilazapril base; hydrochlorothiazide 12.5mg - film coated tablet - 5 mg/12.5 mg - active: cilazapril monohydrate 5.22mg equivalent to 5 mg cilazapril base hydrochlorothiazide 12.5mg excipient: hyprolose hypromellose iron oxide red macrogol 8000 maize starch microcrystalline cellulose sodium stearyl fumarate titanium dioxide - apo-cilazapril/hctz is indicated for the treatment of patients with hypertension who are not adequately controlled on monotherapy.

New Zealand - English - Medsafe (Medicines Safety Authority)

clinect nz pty limited - diclofenac sodium 100mg - modified release tablet - 100 mg - active: diclofenac sodium 100mg excipient: dextrates hyetellose hypromellose iron oxide red iron oxide yellow macrogol 3350 magnesium stearate microcrystalline cellulose titanium dioxide - diclofenac is used for the relief of moderate pain and inflammation in: - rheumatic disorders: e.g. ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis including juvenile rheumatoid arthritis, painful syndromes of the vertebral column, nonarticular rheumatism. - painful post-operative inflammation and swelling (including dental and orthopaedic procedures). - painful or inflammatory gynaecological conditions e.g. primary dysmenorrhoea. - in keeping with general therapeutic principles, the underlying disease should be treated with basic therapy, as appropriate. diclofenac provides symptomatic relief but has not been shown to halt or reverse the underlying disease process. fever alone is not an indication.

New Zealand - English - Medsafe (Medicines Safety Authority)

clinect nz pty limited - diclofenac sodium 75mg - modified release tablet - 75 mg - active: diclofenac sodium 75mg excipient: carnauba wax dextrates hyetellose hypromellose iron oxide red macrogol 3350 magnesium stearate microcrystalline cellulose purified water titanium dioxide - diclofenac is used for the relief of moderate pain and inflammation in: - rheumatic disorders: e.g. ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis including juvenile rheumatoid arthritis, painful syndromes of the vertebral column, nonarticular rheumatism. - painful post-operative inflammation and swelling (including dental and orthopaedic procedures). - painful or inflammatory gynaecological conditions e.g. primary dysmenorrhoea. - in keeping with general therapeutic principles, the underlying disease should be treated with basic therapy, as appropriate. diclofenac provides symptomatic relief but has not been shown to halt or reverse the underlying disease process. fever alone is not an indication.

New Zealand - English - Medsafe (Medicines Safety Authority)

apotex nz ltd - montelukast sodium 4.16mg equivalent to 4 mg motelukast - chewable tablet - 4 mg - active: montelukast sodium 4.16mg equivalent to 4 mg motelukast excipient: aspartame cherry flavour 501027 ap0551 croscarmellose sodium iron oxide red magnesium stearate mannitol microcrystalline cellulose - apo-montelukast is indicated in adult and paediatric patients 2 years of age and older for the prophylaxis and chronic treatment of asthma, including the prevention of day- and night-time symptoms and the prevention of exercise-induced bronchospasm.